Ventris Medical recently received FDA 510(k) clearance for its Amplify standalone bone graft putty in the intervertebral disc space.
The Newport Beach, California-based company designed Amplify to optimize cell proliferation and bone formation. It comprises the Amplify biphasic (HA-to-βTCP) ceramic granules suspended in an alkaline oxide polymer carrier. It can be used standalone or combined with autograft bone as a bone graft extender.
“We are very pleased to receive FDA clearance for Amplify Synthetic Bone Graft Putty for the intervertebral disc space. This technology combines 2 heavily studied biphasic mineral components, which are surface activated through our patented process and suspended in our proprietary polymer carrier,” CEO Russell Cook said in a news release. In a market crowded with a plethora of commodity offerings, our company mission is to develop next-generational devices that bring excitement to the surgeon community as well as our…